Refractory AML: Clinical Trials

2 trials for Refractory AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Refractory AML: new trials by email Literature Review of Refractory AML trials Research Report on Refractory AML

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
Venetoclax Oral Tablet - Relapsed Adult AML, Refractory AML
Phase 1 / Phase 2CompletedTechnische Universität Dresden552020-04-062026-09-02
Phase 1 Study of Quizartinib
AC220 - Relapsed AML, Refractory AML
Phase 1CompletedDaiichi Sankyo Co., Ltd.172016-02-012019-02-12

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Neoplasms (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms (1)

Interventions

venetoclax (1)

Sponsors

Daiichi Sankyo Co., Ltd. (1)  ·  Technische Universität Dresden (1)

Countries

Germany (1)  ·  Japan (1)

Results publications

PMID 31359361, PMID 41791831